课题基金 / 基金详情

项目摘要

项目成果

Brian L Black的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):颅面畸形占所有出生缺陷的近三分之一,是婴儿发病率和死亡率的严重原因。尽管它们普遍存在,但导致大多数头面部缺陷的潜在遗传和分子机制在很大程度上仍不清楚。这些研究的长期目标是确定控制颅面发育的分子和遗传途径,以达到再生和修复、组织工程以及先天性颅面出生缺陷的诊断和干预的目的。具体地说,这一应用侧重于鉴定参与颅面发育的转录途径和机制。最近的工作在小鼠身上发现了一种新的皮埃尔·罗宾序列(PrS)的遗传模型。每800名活产儿中约有1名发生呼吸窘迫综合征,其特征是下颌骨小、舌头位置不当和腭裂后裂,可导致上呼吸道阻塞和喂养困难。以前,人们认为PrS的发生是由于环境因素限制了下颌骨的生长,但现在很清楚的是,这个序列也有一个未知的遗传成分(S)。携带Dlx5/6基因座的一个突变等位基因和MEF2C等位基因的一个突变副本的小鼠出生时就会死于类似于PRS的头面部缺陷。Dlx5/6基因座编码两个远端无亲缘关系的同源框转录因子,而MEF2C基因座编码一个MADS盒转录因子。除了遗传上的相互作用外,MEF2C和Dlx5还相互协作,诱导强大的协同转录反应。这一假设的基础是Dlx5/6和MEF2C在内皮素受体信号下游形成一个转录复合体,该复合体对于头面部发育所需的一组基因的激活是必不可少的,以及Dlx5/6-MEF2C靶基因的突变或异常表达导致了颅面畸形,如PRS。为了解决这些假设,本文提出了三个具体目标。目标1将定义Dlx5和MEF2C之间的物理和功能相互作用,以及这如何导致转录激活。其目标是确定在颅面发育过程中控制基因表达的转录机制。目的2详细分析MEF2C-Dlx5/6双杂合子的头面部缺陷。我们的目标是确定双杂合子中潜在的下颌和腭部表型的可能的细胞机制,以了解这些过程如何控制上颌闭合和下颌的生长。目的3将利用转基因小鼠的方法,鉴定头面部间充质中MEF2C转录的上游调控因子,并确定MEF2C是否是内皮素信号通路的直接靶点。我们的目标是将MEF2C置于转录途径中,并确定内皮素信号在头面部发育中的即时转录效应。 公共卫生相关性:头面部畸形占所有出生缺陷的近三分之一,估计每300名活产中就有1名发生,是婴儿发病率和死亡率的严重原因。尽管头面部出生缺陷很普遍,但导致这些异常的潜在遗传和分子机制在很大程度上仍不清楚。这些研究将有助于理解控制颅面发育的分子和遗传机制,这对于确定如何重新激活或调节这些程序以达到再生和修复、组织工程以及头面部出生缺陷的诊断和干预是至关重要的。
英文摘要
DESCRIPTION (provided by applicant): Craniofacial anomalies account for nearly one-third of all birth defects and are a severe cause of morbidity and mortality in infants. In spite of their prevalence, the underlying genetic and molecular mechanisms causing most craniofacial defects remain largely unknown. The long-term goal of the proposed studies is to define the molecular and genetic pathways that control craniofacial development for the purpose of regeneration and repair, tissue engineering, and the diagnosis of and intervention into congenital craniofacial birth defects. Specifically, this application is focused on the identification of the transcriptional pathways and mechanisms involved in craniofacial development. Recent work has identified a novel genetic model for Pierre Robin Sequence (PRS) in mice. PRS occurs in about 1 in every 800 live births and is characterized by small lower jaw, improperly positioned tongue and posterior cleft of the palate, which can result in upper airway obstruction and feeding difficulties. Previously, it was thought that PRS occurred as a result of environmental factors that restrict outgrowth of the mandible, but it is now quite clear that this sequence also has an undefined genetic component(s). Mice that carry one mutant allele of Dlx5/6 locus and one mutant copy of the Mef2c allele die at birth from craniofacial defects resembling PRS. The Dlx5/6 locus encodes two Distal-less related homeobox transcription factors, while the Mef2c locus encodes a MADS box transcription factor. In addition to their genetic interaction, MEF2C and Dlx5 cooperate to induce a robust synergistic transcriptional response. The hypotheses underlying this proposal are that Dlx5/6 and MEF2C form a transcriptional complex downstream of endothelin receptor signaling, that this complex is essential for the activation of a subset of genes that are required for craniofacial development, and that mutations or aberrant expression of Dlx5/6-MEF2C target genes contributes to craniofacial anomalies such as PRS. To address these hypotheses, three specific aims are proposed. Aim 1 will define the physical and functional interaction between Dlx5 and MEF2C and how this results in transcriptional activation. The goal is to define the transcriptional mechanisms that control gene expression during craniofacial development. Aim 2 will analyze the craniofacial defects in Mef2c-Dlx5/6 double heterozygotes in detail. The goal is to identify possible cellular mechanisms underlying the mandible and palate phenotypes in double heterozygotes to understand how these processes control palate closure and jaw growth. Aim 3 will identify upstream regulators of Mef2c transcription in craniofacial mesenchyme and will determine whether Mef2c is a direct target of the endothelin signaling pathway, using a transgenic mouse approach. The goals are to place Mef2c into a transcriptional pathway and to identify the immediate transcriptional effectors of endothelin signaling in craniofacial development. PUBLIC HEALTH RELEVANCE: Craniofacial anomalies, which account for nearly one third of all birth defects and are estimated to occur in 1 every 300 live births, are a severe cause of morbidity and mortality in infants. In spite of the prevalence of craniofacial birth defects, the underlying genetic and molecular mechanisms causing these anomalies remain largely unknown. The proposed studies will contribute to the understanding of the molecular and genetic mechanisms controlling craniofacial development, which is essential for determining how to reactivate or modulate these programs for the purpose of regeneration and repair, tissue engineering, and the diagnosis of and intervention in craniofacial birth defects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10471991
  • 项目类别:
  • 资助金额:
    $50.91万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10006190
  • 项目类别:
  • 资助金额:
    $51.63万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
Project 3: Control of cardiac transcription by MEF2 and myocardin
  • 批准号:
    10245031
  • 项目类别:
  • 资助金额:
    $51.71万
  • 财政年份:
    2019
  • 负责人:
    Brian L Black
  • 依托单位:
NAVBO Workshops at Vascular Biology 2017
海外基金